Abstract
In the earlier published article, the ethical approval number of the Methods’ section was wrongly provided by the authors. The correct approval number should be: NKYY_YWKT_IRB_2021_009_01.
 New citation: Qian D, Luan X, Zhang Y. Effect of low molecular weight heparin and ulinastatin as a combined therapy on soluble myeloid cell expression and intestinal mucosal function in patients with severe pancreatitis. Trop J Pharm Res 2022; 21(7):1515-1521 doi: 10.4314/tjpr.v21i7.23 Erratum: 2022; 21(11): 2493 doi: http://dx.doi.org/10.4314/tjpr.v 21i11.32
 Earlier citation: Qian D, Luan X, Zhang Y. Effect of low molecular weight heparin and ulinastatin as a combined therapy on soluble myeloid cell expression and intestinal mucosal function in patients with severe pancreatitis. Trop J Pharm Res 2022; 21(7):1515-1521 doi: 10.4314/tjpr.v21i7.23
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
